{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:48:56Z","timestamp":1783442936123,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00459-7","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T08:13:03Z","timestamp":1743495183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The patterns and spectrum of BRCA1 and BRCA2 mutations in Iranian breast and ovarian cancer patients"],"prefix":"10.1007","volume":"24","author":[{"given":"Shayan","family":"Forghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Mirzaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Forghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mahdavi Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hojjat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atieh","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Tabarestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,30]]},"reference":[{"issue":"11","key":"459_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jama.2014.12483","volume":"312","author":"MC King","year":"2014","unstructured":"King MC, Levy-Lahad E, Lahad A (2014) Population-based screening for BRCA1 and BRCA2: 2014 Lasker award. JAMA 312(11):1091\u20131092","journal-title":"JAMA"},{"issue":"11","key":"459_CR2","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","volume":"77","author":"EB Claus","year":"1996","unstructured":"Claus EB et al (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77(11):2318\u20132324","journal-title":"Cancer"},{"issue":"2","key":"459_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.2005.10.042","volume":"23","author":"JE Garber","year":"2005","unstructured":"Garber JE, Offit K (2005) Hereditary cancer predisposition syndromes. J Clin Oncol 23(2):276\u2013292","journal-title":"J Clin Oncol"},{"issue":"23","key":"459_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402\u20132416","journal-title":"JAMA"},{"issue":"13","key":"459_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR et al (2015) Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313(13):1347\u20131361","journal-title":"JAMA"},{"issue":"2","key":"459_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"459_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","volume":"7","author":"SM Domchek","year":"2006","unstructured":"Domchek SM et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223\u2013229","journal-title":"Lancet Oncol"},{"issue":"9","key":"459_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967\u2013975","journal-title":"JAMA"},{"issue":"34","key":"459_CR9","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1200\/JCO.2016.67.0554","volume":"34","author":"KN Maxwell","year":"2016","unstructured":"Maxwell KN et al (2016) Population frequency of germline BRCA1\/2 mutations. J Clin Oncol 34(34):4183\u20134185","journal-title":"J Clin Oncol"},{"issue":"13","key":"459_CR10","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","volume":"34","author":"ER Thompson","year":"2016","unstructured":"Thompson ER et al (2016) Panel testing for Familial breast cancer: calibrating the tension between research and clinical care. J Clin Oncol 34(13):1455\u20131459","journal-title":"J Clin Oncol"},{"issue":"8","key":"459_CR11","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","volume":"91","author":"AC Antoniou","year":"2004","unstructured":"Antoniou AC et al (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91(8):1580\u20131590","journal-title":"Br J Cancer"},{"issue":"10","key":"459_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/jmedgenet-2017-104584","volume":"54","author":"DG Evans","year":"2017","unstructured":"Evans DG et al (2017) Pathology update to the Manchester scoring system based on testing in over 4000 families. J Med Genet 54(10):674\u2013681","journal-title":"J Med Genet"},{"key":"459_CR13","unstructured":"National Institute for Health and Care Excellence (NICE). 4\/24\/2024]; Available from: https:\/\/www.nice.org.uk\/"},{"issue":"11","key":"459_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1158\/1940-6207.CAPR-19-0056","volume":"12","author":"E Ebrahimi","year":"2019","unstructured":"Ebrahimi E et al (2019) The NCCN criterion young age at onset alone is not an indicator of hereditary breast cancer in Iranian population. Cancer Prev Res (Phila) 12(11):763\u2013770","journal-title":"Cancer Prev Res (Phila)"},{"key":"459_CR15","unstructured":"NCCN Guidelines Available from: https:\/\/www.nccn.org\/guidelines\/category_2"},{"issue":"5","key":"459_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"issue":"25","key":"459_CR17","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","volume":"384","author":"ANJ Tutt","year":"2021","unstructured":"Tutt ANJ et al (2021) Adjuvant Olaparib for patients with BRCA1- or BRCA2-Mutated breast cancer. N Engl J Med 384(25):2394\u20132405","journal-title":"N Engl J Med"},{"issue":"1","key":"459_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000526746","volume":"18","author":"ME Akbari","year":"2023","unstructured":"Akbari ME et al (2023) Ten-Year survival of breast cancer in Iran: A National study (Retrospective cohort study). Breast Care (Basel) 18(1):12\u201321","journal-title":"Breast Care (Basel)"},{"issue":"2","key":"459_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41416-021-01597-2","volume":"126","author":"YD Guzm\u00e1n-Arocho","year":"2022","unstructured":"Guzm\u00e1n-Arocho YD et al (2022) Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer. Br J Cancer 126(2):302\u2013309","journal-title":"Br J Cancer"},{"issue":"2","key":"459_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1470-2045(17)30891-4","volume":"19","author":"ER Copson","year":"2018","unstructured":"Copson ER et al (2018) Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. Lancet Oncol 19(2):169\u2013180","journal-title":"Lancet Oncol"},{"issue":"24","key":"459_CR21","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","volume":"298","author":"EM John","year":"2007","unstructured":"John EM et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US Racial\/ethnic groups. JAMA 298(24):2869\u20132876","journal-title":"JAMA"},{"issue":"10","key":"459_CR22","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115(10):2222\u20132233","journal-title":"Cancer"},{"issue":"1","key":"459_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N et al (2012) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomarkers Prev 21(1):134\u2013147","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"459_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13053-019-0105-9","volume":"17","author":"C Farra","year":"2019","unstructured":"Farra C et al (2019) BRCA mutation screening and patterns among high-risk Lebanese subjects. Hered Cancer Clin Pract 17:4","journal-title":"Hered Cancer Clin Pract"},{"key":"459_CR25","doi-asserted-by":"crossref","unstructured":"van Wyk C et al (2024) The Manchester scoring system for predicting BRCA1\/2 mutations underperforms in Arabic Omani breast cancer patients. J Genet Couns","DOI":"10.1002\/jgc4.1939"},{"issue":"5","key":"459_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/humu.23406","volume":"39","author":"TR Rebbeck","year":"2018","unstructured":"Rebbeck TR et al (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39(5):593\u2013620","journal-title":"Hum Mutat"},{"issue":"4","key":"459_CR27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ijc.32176","volume":"145","author":"SP Bhaskaran","year":"2019","unstructured":"Bhaskaran SP et al (2019) Germline variation in BRCA1\/2 is highly ethnic-specific: evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients. Int J Cancer 145(4):962\u2013973","journal-title":"Int J Cancer"},{"issue":"10","key":"459_CR28","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/humu.23804","volume":"40","author":"TM Friebel","year":"2019","unstructured":"Friebel TM et al (2019) BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry. Hum Mutat 40(10):1781\u20131796","journal-title":"Hum Mutat"},{"issue":"15","key":"459_CR29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/JCO.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian AW et al (2019) Genetic testing and results in a Population-Based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol 37(15):1305\u20131315","journal-title":"J Clin Oncol"},{"key":"459_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-2148-14-155","volume":"14","author":"DI Lou","year":"2014","unstructured":"Lou DI et al (2014) Rapid evolution of BRCA1 and BRCA2 in humans and other primates. BMC Evol Biol 14:155","journal-title":"BMC Evol Biol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00459-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:57:42Z","timestamp":1750913862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00459-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,30]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00459-7","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,30]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}